It's been a tough year for Novo Nordisk, the Danish pharmaceutical company behind the GLP-1 drugs Ozempic and Wegovy.

OMAHA, Neb. (WOWT) - The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or Zepbound were previously in a shortage.

Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular ...

In this week's newsletter, also read about why Indian pharma companies are fast-tracking alternatives to weight-loss ...

Online prescriptions – for everything from weight loss to medicinal cannabis – is now a big business backed by Woolworths and ...

A look inside the rise of "The Barbie Drug," an unregulated, understudied injection that promises bronzed skin—and a load of ...

A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...

FDA Commissioner Dr. Marty Makary said Thursday that the United States needs to transform its health care approach from ...

Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss copycats.

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy ...

Covid vaccines from Pfizer and Moderna must carry expanded warning labels informing patients of the risk of rare heart inflammation. The FDA is also cracking down on off-brand GLP-1 drugs. Other ...